ArticleNPJ genomic medicine2026

BCL2 promoter region mutations are an independent marker of BCL2 level in lymphoid malignancies.

Daniel Kuznicki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.